This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wei Zhao: Innovator in Biopharmaceuticals
Introduction
Wei Zhao is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic proteins. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Wei Zhao holds a patent for a bi-functional protein designed to target PD-1 and TGF-beta. This innovative approach has the potential to enhance cancer treatment by modulating immune responses. The patent reflects his dedication to addressing complex medical challenges through scientific innovation. He has 1 patent to his name.
Career Highlights
Wei Zhao is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His role at the company allows him to collaborate with other experts and contribute to groundbreaking research and development projects. His work has positioned him as a key figure in the biopharmaceutical sector.
Collaborations
Wei Zhao has worked alongside talented colleagues, including Yingchun Li and Haili Lv. These collaborations have fostered a dynamic research environment, enabling the team to push the boundaries of innovation in their field.
Conclusion
Wei Zhao's contributions to biopharmaceuticals exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements that may lead to improved therapies for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile